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Background and PurposezzThis study investigated the structural and functional changes in 
the motor system in amyotrophic lateral sclerosis (ALS; n=25) and behavioral-variant fronto-
temporal dementia (bvFTD; n=17) relative to healthy controls (n=37).
MethodszzStructural changes were examined using a region-of-interest approach, applying 
voxel-based morphometry for gray-matter changes and diffusion tensor imaging for white-mat-
ter changes. Functional changes in the motor system were elucidated using threshold-tracking 
transcranial magnetic stimulation (TMS) measurements of upper motor-neuron excitability.
ResultszzThe structural analyses showed that in ALS there were more white-matter changes in 
the corticospinal and motor-cortex regions and more gray-matter changes in the cerebellum in 
comparison to controls. bvFTD showed substantial gray- and white-matter changes across vir-
tually all motor-system regions compared to controls, although the brainstem was affected less 
than the other regions. Direct comparisons across patient groups showed that the gray- and 
white-matter motor-system changes inclusive of the motor cortex were greater in bvFTD than 
in ALS. By contrast, the functional integrity of the motor system was more adversely affected in 
ALS than in bvFTD, with both patient groups showing increased excitability of upper motor 
neurons compared to controls.
ConclusionszzCross-correlation of structural and functional data further revealed a neural 
dissociation of different motor-system regions and tracts covarying with the TMS excitability 
across both patient groups. The structural and functional motor-system integrities appear to be 
dissociated between ALS and bvFTD, which represents useful information for the diagnosis of 
motor-system changes in these two disorders.
Key Wordszz frontotemporal dementia, amyotrophic lateral sclerosis, voxel-based  
morphometry, diffusion tensor imaging, transcranial magnetic stimulation.
Dissociation of Structural and Functional Integrities 
of the Motor System in Amyotrophic Lateral Sclerosis 
and Behavioral-Variant Frontotemporal Dementia
INTRODUCTION
Behavioral-variant frontotemporal dementia (bvFTD) and amyotrophic lateral sclerosis 
(ALS) are neurodegenerative disorders that are increasingly recognized to lie on a disease 
continuum at the clinical, genetic, and pathological levels.1-3 Despite the increasing clarity of 
the underlying clinical, genetic, and pathological commonalities, there remains a lack of 
knowledge of the neural correlates across the ALS-FTD continuum. The neuroanatomi-
cal correlates of degeneration have been established within the FTD subtypes and also to 
some extent in ALS. However, to our knowledge only one previous study has directly con-
trasted the gray- and white-matter changes across the whole continuum, and showed that 
the prefrontal gray- and white-matter changes were substantially greater in bvFTD than 
in ALS. By contrast, there were substantially more corticospinal white-matter changes in 
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ALS than in bvFTD, while both patient groups showed mo-
tor-cortex changes and associated white-matter degeneration.
These findings of motor-cortex changes across the contin-
uum raise crucial questions regarding the degree to which the 
whole motor-system network is dysfunctional in ALS and 
FTD. At a neurophysiological level, threshold-tracking tran-
scranial magnetic stimulation (TT-TMS) has shown early cor-
tical hyperexcitability in ALS5,6 as well as bvFTD.7 Of particu-
lar interest was the finding of TMS motor hyperexcitability—
which is a functional marker of motor-cortex impairment4—
in a high proportion of patients with FTD.7 These findings 
demonstrate that there are functional changes in the motor 
cortex in both ALS and FTD. However, the structural gray-
matter changes within the motor system (in the supplemen-
tary motor cortex, motor cortex, thalamus, striatum, brain-
stem, and cerebellum) and its connecting white-matter tracts 
across the continuum remain largely unknown. More impor-
tantly, the relationship between measures of functional mo-
tor integrity (i.e., TMS) and structural gray- and white-mat-
ter changes has not been explored. Further elucidation of this 
complex relationship is important for understanding motor 
dysfunction in ALS and FTD.
The current study addressed these issues by conducting a 
region-of-interest (ROI) analysis of the cortical and subcor-
tical motor-system areas as well as their white-matter con-
nections across ALS and bvFTD clinical phenotypes with the 
aim of identifying the neural basis of motor dysfunction in 
both disorders (see Fig. 1 for an overview of the regions and 
tracts included). A particularly important feature of this study 
was the inclusion of the cerebellum and thalamus and their 
white-matter connections in the ROI analyses, since these 
structures have not been investigated in previous ALS and 
FTD neuroimaging studies. In addition, a subset of patients 
was assessed for functional integrity of the corticomotor neu-
rons and inhibitory interneurons using TT-TMS. These phys-
iological results were cross-correlated with the results from 
the gray- and white-matter ROI analyses to investigate the 
neuroanatomical correlates of motor-cortex hyperexcitability. 
We hypothesized that there is a gradation of structural 
changes in ALS and FTD, with gray-matter changes being 
particularly prevalent in bvFTD and white-matter changes 
predominating in ALS. We further hypothesized that func-
tional neurophysiological indices of motor dysfunction would 
be affected more in ALS, and that these changes would be re-
lated to motor-cortex atrophy. 
METHODS
Case selection
A total of 79 participants took part in this study. Patients were 
recruited from the FRONTIER FTD Research Clinic as well 
as specialist ALS multidisciplinary clinics in Sydney, Austra-
lia, which yielded a sample comprising 25 bvFTD patients, 
17 ALS, and 37 controls. All FTD patients met current con-
sensus criteria for bvFTD,8 showing the progressive behav-
ioral and/or cognitive decline characteristic of this dementia 
subset, including some or all of the following features: dis-
inhibition, apathy, inertia, loss of empathy, perseveration, 
stereotypic behaviors, and dysexecutive syndrome. The pa-
tients also met criteria for MRI evidence of atrophy localized 
to frontal and/or temporal lobes. All of the enrolled ALS pa-
tients had “clinically definite” or “clinically probable” ALS ac-
cording to El Escorial Criteria Revised.9 These criteria required 
either clinical or electromyographic evidence of combined 
upper and lower motor-neuron dysfunction in three separate 
spinal or bulbar regions of innervation. The ALS patients were 
functionally staged using the ALS Functional Rating Scale-
Revised (ALSFRS-R).10 The excluded patients included those 
with respiratory compromise, as indicated by a forced vital 
capacity of <70% or symptoms suggestive of nocturnal hy-
poventilation, as well as those with other neuromuscular or 
neurological diseases. The bvFTD group did not include any 
Fig. 1. Regions of interest (ROIs) included in the study. Gray-matter integrity is indicated by blue shading in the respective ROIs, and white-matter 
integrity is indicated by dashed lines of different styles (none, partly, and full) surrounding and connecting the regions. BSt: brainstem, CB: cere-
bellum, MCx: motor cortex, Str/Thal: striatum and thalamus.
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patients who manifested features of ALS. Two bvFTD patients 
but none of the ALS patients carried the C9orf72 mutation. 
No other mutations (e.g., MAPT, PGRN, or SOD) were de-
tected in the remaining patients. A group of 37 healthy adults 
was included as controls, and the three study groups were 
matched for age, gender, education, and duration of disease. 
Testing and scanning were conducted at the first clinic visit 
of each patient.
Ethics statement
All participants or their Person Responsible provided written 
informed consent in accordance with the Declaration of Hel-
sinki. This study was approved by the South Eastern Sydney 
Local Health District and the University of New South Wales 
ethics committees. The genetic status of all patients was un-
known.
General cognitive testing
The Addenbrooke’s Cognitive Examination Revised (ACE-R) 
was used to assess the cognitive function of the patients across 
the following five subscales: attention and orientation, mem-
ory, fluency, language, and visuospatial cognition.11 The Cam-
bridge Behavioural Inventory Revised (CBI-R)12 was used to 
map the neuropsychiatric topography of the patient and the 
material impact on daily life. This test has been corroborat-
ed by the Neuropsychiatric Inventory as an effective measure 
of neuropsychiatric symptoms. 
Imaging acquisition
Subjects were scanned using a 3-T Philips MRI scanner. T1-
weighted images were acquired using the following parame-
ters: coronal orientation, matrix=256×256, in-plane resolu-
tion=200×161 mm2, slice thickness=1 mm, and TE/TI= 
2.6/5.8 ms. Diffusion-tensor imaging (DTI) was performed 
using the following parameters: 32 gradients, TR/TE/TI= 
8400/68/90 ms, b=1000 s/mm2, five 2.5 mm horizontal slic-
es, end resolution=2.562×562.5 mm3, matrix=96×96, and 
two repetitions.
Voxel-based morphometry and DTI analyses
An ROI mask was created using the Harvard-Oxford prob-
abilistic cortical and subcortical atlases for gray-matter re-
gions, and the Johns Hopkins University white-matter trac-
tography atlas for white-matter regions. The following regions 
were included: motor cortex (precentral gyrus, postcentral 
gyrus, and supplementary motor area), thalamus, striatum 
(putamen, caudate, and globus pallidus), brainstem, cerebel-
lum, and the associated connecting white-matter tracts be-
tween these structures (Fig. 1).
Voxel-based morphometry (VBM) and DTI analyses were 
performed as detailed previously.4 The significance cutoff for 
all comparisons between patient and control groups was p< 
0.05, with correction for multiple comparisons performed us-
ing spatial family-wise error (FWE) correction. The interpa-
tient comparisons did not survive FWE correction and were 
tested at a significance level of p<0.05 with correction for the 
false discovery rate (FDR), with the exception of the ALS< 
bvFTD contrast, which did not survive multiple comparison 
correction and is reported at an uncorrected level of p<0.0001 
and a cluster threshold of 20 contiguous voxels.
TMS was applied to 28 patients (15 MND and 13 FTD) 
within 1 month of MRI scanning. A paired-pulse TT-TMS 
strategy was applied in accordance with a previously report-
ed technique.5 Motor-cortex excitability short-interval intra-
cortical inhibition (SICI) variables were entered in a covari-
ate-only statistical model with a [1] t-contrast, providing an 
index of association between decreasing gray-matter vol-
ume and lower scores for the experimental measures. 
The anatomical locations of significant results were overlaid 
on the MNI standard brain atlas, with maximum coordinates 
provided in MNI stereotaxic space. Anatomical labels were 
determined with reference to the Harvard-Oxford probabilis-
tic cortical atlas. The covariance contrasts were tested at a sig-
nificance level of p<0.05 with correction for the FDR. 
Table 1. Demographic and clinical characteristics of the study participants
Demographic ALS bvFTD Controls F test
Number of subjects 17 25 37
Sex (male:female) 12:5 16:9 19:18 n/s
Age, years 58.10±9.43 61.83±11.70 64.05±5.10 n/s
Education, years 13.68±3.21 12.23±2.76 13.21±2.43
Disease duration, years 1.95±5.75 4.34±2.49 n/a n/s
ACE-R total score (out of 100) 86.82±9.88 71.88±21.28 94.16±3.78 *
CBI-R total score (out of 100) 21.14±13.48 38.30±21.95 3.67±3.78 *
Data are mean±SD values. F values indicate significant differences between groups, *p<0.001. Tukey post-hoc tests were used to compare differences 
between group pairs.
ACE-R: Addenbroke’s Cognitive Examination Revised, ALS: amyotrophic lateral sclerosis, bvFTD: behavioral-variant frontotemporal dementia, CBI-R: 
Cambridge Behavioural Inventory Revised, n/s: not significant.
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RESULTS
Demographics, functional, cognitive, 
and behavioral profiles
None of the demographic variables differed significantly be-
tween the patient groups and controls. Moreover, the disease 
duration did not differ significantly between the patient 
groups (Table 1).
In terms of functional status, 14 of 15 ALS patients were 
staged using the ALSFRS-R within 1 month of the brain im-
aging study, and the median ALSFRS-R score was 43 (range 
36–46).
The score for the general cognitive measure (ACE-R) dif-
fered significantly between the patient groups (p<0.001). Post-
hoc comparisons showed that the total ACE-R score was sig-
nificantly higher for ALS patients than for bvFTD patients, 
who did not differ significantly from controls. However, the 
general cognition score was significant lower for bvFTD pa-
tients than for controls.
The CBI-R behavioral score differed significantly between 
the groups (p<0.001), with post-hoc Tukey tests revealing 
significant differences in all pairwise comparisons (p<0.001). 
These results confirm that bvFTD patients show more-se-
vere neuropsychiatric disturbances than do ALS patients.
VBM and DTI
Comparisons with controls
ALS patients showed only minor gray-matter changes relative 
to controls, mainly in the motor cortex, cerebellum, and thala-
mus. By contrast, ALS patients showed substantially greater 
white-matter changes in these regions as well as in the brain-
stem. Additionally, ALS patients showed substantial corticospi-
nal white-matter tract changes throughout the brain (Fig. 2A).
Compared to controls, severe degenerative changes across 
all motor-system regions were evident in bvFTD patients, 
with the cerebellum being particularly affected. Similarly, 
white-matter changes were widespread and severe in bvFTD, 
Fig. 2. Voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) findings for (A) amyotrophic lateral sclerosis (ALS) vs. controls and (B) 
behavioral-variant frontotemporal dementia (bvFTD) vs. controls. VBM and DTI findings are shown in blue and red, respectively. Colored voxels 
show regions that were significant in the analysis at p<0.05 with correction for the family-wise error. For all clusters, t>3.50. Clusters are overlaid 
on the MNI standard brain atlas. BSt: brainstem, CB: cerebellum, MCx: motor cortex, Str/Thal: striatum and thalamus.
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affecting all of the ROIs (Fig. 2B).
Comparison between patient groups
Direct comparisons of ALS and bvFTD revealed minimal gray-
matter atrophy in the cerebellum and white-matter changes 
in the left thalamus in ALS patients (Fig. 3). The bvFTD pa-
tients showed substantially more significant atrophy in the 
motor-cortex, striatal, thalamic, and cerebellar areas, as well as 
in the connecting white-matter tracts between these struc-
tures. A particularly notable observation was the absence of 
significant differences in the brainstem between the two 
groups. 
Transcranial magnetic stimulation
TT-TMS revealed substantial abnormalities in both the 
ALS and bvFTD groups, with a lower maximal motor evoked 
potential (MEP) amplitude, higher MEP/compound-motor-
action-potential ratio, and prolonged MEP latency com-
pared to controls (Table 2). The MEP latency was significant-
ly prolonged in bvFTD relative to ALS. The central motor 
Fig. 3. VBM and DTI findings for (A) ALS vs. bvFTD and (B) bvFTD vs. ALS. VBM and DTI findings are shown in blue and red, respectively. Colored 
voxels show regions that were significant in the analysis at p<0.05 with correction for FWE. For all clusters, t>3.50. Clusters are overlaid on the 
MNI standard brain atlas. ALS: amyotrophic lateral sclerosis, BSt: brainstem, bvFTD: behavioral-variant frontotemporal dementia, CB: cerebellum, 
DTI: diffusion tensor imaging, FWE: family-wise error, MCx: motor cortex, Str/Thal: striatum and thalamus, VBM: voxel-based morphometry.
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Table 2. Parameters used for threshold-tracking transcranial magnetic stimulation in patients with motor-neuron disease (MND), combined fron-
totemporal dementia (FTD) and MND, and FTD
TMS parameters ALS bvFTD Controls F test
Number of subjects 15 13 16
RMT, % 58.4±4.8 60.1±6.2 59.9±2.5 n/s
MEP amplitude, mV 2.4±0.4 2.7±0.4 3.7±0.6 *
MEP amplitude/CMAP ratio, % 41.3±8.0 32.2±4.9 21.7±3.7 **
MEP latency, ms 25.5±0.8 28.2±0.4 20.0±0.5 *
CMCT, ms 9.1±0.5 6.4±0.7 5.6±0.5 **
Average SICI, % 1.5±3.5 5.7±2.5 10.7±1.2 *
SICI1, % -0.1±1.9 2.9±2.5 11.7±1.7 **
SICI3, % 4.1±4.5 9.5±3.1 15.5±1.9 *
ICF, % -5.6±2.5 -1.6±0.7 –1.0±1.3 n/s
Maximum cortical silent period, ms 177.3±10.7 198.0±5.1 259.1±70.1 *
Data are mean±SEM values. F values indicate significant differences between groups, *p<0.05, **p<0.01.
CMAP: compound motor action potential, CMCT: central motor conduction time, ICF: intracortical facilitation, MEP: motor evoked potential, n/s: not 
significant, RMT: resting motor threshold, SICI: short-interval intracortical inhibition, TMS: transcranial magnetic stimulation.
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conduction time was significantly prolonged in ALS rela-
tive to bvFTD and controls. The maximal cortical silent pe-
riod in ALS patients was significantly delayed compared to 
controls, but did not differ from that in bvFTD patients.
The reduction in SICI differed significantly between the 
patient groups and controls (Fig. 4A). TT-TMS measures the 
stimulus intensity required to achieve the target MEP am-
plitude of 0.2 mV. SICI normally increases with the inter-
stimulus interval, peaking at an interstimulus interval of 3 
ms. The increase in stimulus intensity was significantly at-
tenuated in both ALS and bvFTD compared to controls, with 
no differences between the two patient groups. This pattern 
was similar for SICI at 1 and 3 ms (Table 2, Fig. 4B).
Finally, intracortical facilitation and the resting motor 
threshold did not differ significantly among the groups. Sim-
ilarly, there were no intergroup differences in the neurophysi-
ological index (mean±SD: controls=2.2±0.2, ALS=0.7±0.2, 
bvFTD=1.0±0.3; all p<0.05).
Neuroimaging covariance analyses of TMS findings
The neuroimaging analyses were restricted to the SICI neu-
ral correlate of hyperexcitability, which has been shown to be 
a reliable and specific marker of motor-cortex dysfunction 
and ALS pathology.13,14 VBM results for the average SICI (blue 
shading in Fig. 5A) revealed that atrophy in the motor cor-
tex covaried with TMS hyperexcitability in ALS. A particu-
larly notable observation was that for bvFTD patients (yel-
low/red shading in Fig. 5A), atrophy in the supplementary 
motor cortex showed the strongest association with hyper-
excitability, with only a limited involvement of motor-cortex 
areas. Finally, cerebellar atrophy was correlated with the av-
erage SICI score in both the ALS and bvFTD groups. 
Parallel white-matter analysis using DTI (ALS=blue shad-
ing; bvFTD=yellow/red shading) (Fig. 5B) revealed that the 
average SICI score was significantly correlated with motor-
cortex, brainstem, and thalamocerebellar tract white-matter 
changes in ALS patients, but only with bilateral corticospinal 
tract changes at the level of the internal capsule in bvFTD 
patients. 
DISCUSSION
The present findings are the first to highlight the presence of 
dissociation between the functional and structural integrities 
of the motor system in ALS and bvFTD. Contrary to our hy-
potheses, white-matter structural changes were not greater in 
ALS patients than in bvFTD patients. Instead, bvFTD patients 
showed more atrophy across all of the motor-system regions 
investigated. In contrast to these structural findings, func-
tional motor-system TMS changes were most pronounced in 
the ALS group. Cross-correlation analyses of structural and 
functional deficits revealed that functional changes in the 
motor system in ALS were mostly associated with motor-
cortex and cerebellar atrophy, as well as corticospinal tract 
degeneration in the brainstem. Supplementary motor-cortex 
atrophy and corticospinal tract changes at the level of the 
internal capsule were involved in the generation of the func-
tional deficits evident in bvFTD patients. 
Fig. 4. Threshold-tracking transcranial magnetic stimulation short-interval intracortical inhibition (SICI) results for all groups: across all interstim-
ulus intervals (A) and for the peak interstimulus interval of 3 ms (B). Error bars indicate SEM values. ALS: amyotrophic lateral sclerosis, bvFTD: be-
havioral-variant frontotemporal dementia, MND: motor neuron disease, SEM: standard error of the mean.
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The findings for gray and white matter in bvFTD repli-
cate those of previous studies, showing substantial involve-
ment of the thalamus, brainstem, motor cortex, and their 
underlying white-matter tracts.4,15-18 However, contrary to 
our predictions, the degeneration seen in both the gray and 
white matter in the motor-system network was more wide-
spread in bvFTD patients than in ALS patients. While pro-
gressive degeneration of the motor cortex, brainstem, and 
spinal cord is characteristic of ALS,9,19,20 neuroimaging stud-
ies have found considerable variability in these regions. At-
rophy in the motor cortex is found in 25% of ALS cases,21,22 
although a recent study highlighted that cortical atrophy in 
ALS might largely determine the neuropsychiatric and cog-
nitive changes in these patients.23 A review found that cor-
ticospinal tract degeneration is more consistently observed 
in ALS.19 In line with these findings, we found only minor 
gray-matter changes in the motor cortex, but substantial de-
generation of the corticospinal tract in the motor cortex and 
brainstem. In addition, we replicated previous findings of 
atrophy in the posterior thalamus in sporadic ALS,24 which 
have been recently linked with abnormalities in the C9orf72 
gene.25,26 However, our findings show that such changes 
might also occur in sporadic ALS; this needs to be confirmed 
in independent samples in the future.
More importantly, the current study has revealed a disso-
ciation of the structural and functional integrities of the mo-
tor system in ALS and FTD. The neurophysiological data ob-
tained using the TT-TMS method—in particular the SICI 
index (which is a measure of cortical excitability)—replicated 
the findings of a previous study of ALS and FTD,7 with ALS 
showing more substantial TMS changes, but with both groups 
being significantly abnormal compared to age-matched 
controls. The substantial SICI reduction in ALS despite the 
significantly greater motor-cortex atrophy in bvFTD patients 
was striking. This finding raises issues concerning the rela-
tionship between macroscopic motor-cortex atrophy and 
physiological changes. SICI is thought to reflect interneu-
ron motor-cortex changes,13,14 which might not parallel mac-
roscopic atrophy. However, it can be assumed that greater 
macroscopic changes should occur concurrently with great-
er microscopic changes. Our analysis revealed that motor-
cortex atrophy was strongly related to SICI changes in ALS, 
whereas supplementary motor-cortex changes were corre-
lated with SICI in bvFTD. Thus, although bvFTD patients 
show greater macroscopic motor-cortex atrophy than do ALS 
patients, the motor-cortex changes in ALS affect the inter-
neurons targeted by SICI. Future studies contrasting the mo-
tor-cortex pathologies in ALS and bvFTD could be greatly 
beneficial for elucidating whether these patient groups show 
differences in microscopic motor-cortex changes.
Our cross-correlation analysis also revealed that other up-
per motor-neuron components or their relay stations can 
affect SICI signals. More specifically, we found that cerebel-
lar atrophy was strongly associated with SICI changes, par-
ticularly in ALS. To our knowledge, this is the first study dem-
onstrating this relationship, and shows that different motor-
Fig. 5. Results of VBM (A) and DTI (B) covariation analyses for the average SICI. Results for ALS and bvFTD are shown in light-blue/dark-blue and 
yellow/red shading, respectively. Colored voxels show regions that were significant in the analysis at p<0.05 with correction for the false discovery 
rate (FDR). For all clusters, t>3.50. Clusters are overlaid on the MNI standard brain atlas. ALS: amyotrophic lateral sclerosis, bvFTD: behavioral-vari-
ant frontotemporal dementia, DTI: diffusion tensor imaging, MNI: Montreal Neurological Institute coordinates, SICI: short-interval intracortical in-
hibition, VBM: voxel-based morphometry.
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system areas can modulate upper motor-neuron measures. 
The connecting white-matter tracts may also influence these 
measures, including SICI, as suggested by the DTI covaria-
tion findings. In particular, changes in the corticospinal tract 
white-matter integrity in the motor cortex as well as in the 
brainstem were associated with reduced SICI in ALS, while 
bvFTD patients showed that the corticospinal tract was only 
correlated with SICI. Changes in the brainstem and poten-
tially also in the medulla and spinal cord could significantly 
affect upper motor-neuron measurements in ALS. 
Finally, a striking and novel finding was the presence of 
cerebellar atrophy in both ALS and bvFTD. The cerebellum 
has been implicated in ALS, with neuroimaging studies dem-
onstrating decreased gray-matter volume in the right cere-
bellar lobe24 and disturbed connectivity in its white-matter 
tracts.27 Cerebellar dysfunction is classically associated with 
motor coordination problems such as ataxia, but little evi-
dence has been reported of ALS or FTD patients showing such 
symptoms. One clinicopathological FTLD-MND case study 
found that prominent cerebellar ataxia was associated with 
microscopic but not macroscopic pathology in the cerebel-
lum.28 Cerebellar dysfunction has also been associated with 
neuropsychiatric and cognitive disturbances,29 which is some-
what corroborated by reports that C9orf72 mutations are 
associated with a higher incidence of psychiatric features30 as 
well as macroscopic cerebellar atrophy,25,31 though no direct 
link has been established. In keeping with this notion, we 
found that the cerebellum was more affected in bvFTD than 
in ALS, with the incidence of neuropsychiatric deficits also 
being higher in bvFTD. This suggests that cerebellar dys-
function plays a more general role in neurodegenerative dis-
orders than previously supposed.
In terms of clinical relevance, these findings further sub-
stantiate the notion of a cognitive and motor continuum across 
ALS and FTD. However, it is not yet clear whether the phys-
iological motor changes found in early bvFTD are a harbin-
ger of future significant motor symptoms.7,32 Future longi-
tudinal studies following these motor changes at clinical, 
imaging, and physiological levels over time should establish 
whether the motor-system dysfunction seen in bvFTD will 
eventually lead to full-blown ALS, and elucidate more clearly 
the relationships between various measures of motor dys-
function. Future studies should also investigate whether the 
same pattern of functional and structural changes is observed 
in rarer genetic forms of bvFTD and ALS, such as MAPT, 
FUS, and SOD1.
In conclusion, this study has revealed gray- and white-
matter changes in the motor-cortex—subcortical neural 
networks in both ALS and bvFTD, and that the cerebellum 
may contribute to the motor and neuropsychiatric deficits 
seen in these two disorders. The functional integrity of the 
motor system was worse in ALS that in bvFTD, despite 
there being more structural degeneration of the motor sys-
tem in the latter. Lastly, structural-functional motor-system 
dissociation was also apparent from cross-correlation anal-
yses of the obtained data sets, which shows that different 
patterns of structural integrity were related to the function-
al impairment across groups. These findings will help to 
elucidate the particular changes in ALS and FTD that cause 
motor dysfunction, and thereby inform future diagnostic 
procedures and treatment plans.
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